CAPTRUST FINANCIAL ADVISORS - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$1,544,809
-18.5%
56,920
-7.7%
0.01%
-14.3%
Q2 2023$1,895,582
-14.6%
61,665
+0.0%
0.01%
-30.0%
Q1 2023$2,220,853
-14.4%
61,639
-6.1%
0.01%
-23.1%
Q4 2022$2,594,014
+0.6%
65,638
+2.3%
0.01%
-13.3%
Q3 2022$2,578,000
+21383.3%
64,154
+22175.7%
0.02%
Q2 2022$12,000
+20.0%
288
+11.2%
0.00%
Q1 2022$10,000
+66.7%
259
+76.2%
0.00%
Q4 2021$6,000
-14.3%
147
-29.0%
0.00%
Q3 2021$7,000207
+2857.1%
0.00%
Q2 2021$070.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders